search button

Antitumor effect of the paclitaxel‑eluting membrane in a mouse model

  • Authors:
    • Jin‑Seok Park
    • Seok Jeong
    • Don Haeng Lee
    • Jin Hee Maeng
    • In Suh Park
    • Sangsoo Park

  • View Affiliations

  • Published online on: July 17, 2018     https://doi.org/10.3892/ol.2018.9164
  • Pages: 4537-4542
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Local treatment of primary bile duct cancer, which grows locally at the primary lesion and seldom metastasizes to distant sites, is challenging. The present study evaluated the antitumor effect, systemic toxicity, biodistribution and survival benefit of the paclitaxel‑eluting polyurethane membrane in a tumor model. Membranes containing various amounts of paclitaxel (0, 100, 300, 600 and 1,200 µg/disc) were inserted beneath the tumor mass in mouse models. Tumor size and body weight of the tumor models were monitored for 26 days after insertion of the membrane. The terminal deoxynucleotidyl transferase‑mediated dUTP nick end labeling assay was performed in the tumor tissues. High‑performance liquid chromatography was performed for evaluation of paclitaxel concentration in peripheral tissues. Tumor volumes on day 26 of membrane treatment were decreased in a dose‑dependent manner. No significant difference in body weight was observed in the groups. A greater number of apoptotic cells were counted per high power field in tumor tissues following an increase of paclitaxel concentration. In the 1,200 µg‑group, concentrations of paclitaxel were significantly higher in tumors compared with those of other tissues and serum. The paclitaxel‑eluting membrane demonstrated a significant and dose‑dependent antitumor activity, and did not exert systemic toxicity in the tumor model.
View Figures
View References

Related Articles

Journal Cover

October-2018
Volume 16 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.9
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 6.3
  • CiteScore Rank: Q2: #119/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.725
  • SCImago Journal Rank (SJR): 0.639
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Park JS, Jeong S, Lee DH, Maeng JH, Park IS and Park S: Antitumor effect of the paclitaxel‑eluting membrane in a mouse model. Oncol Lett 16: 4537-4542, 2018
APA
Park, J., Jeong, S., Lee, D.H., Maeng, J.H., Park, I.S., & Park, S. (2018). Antitumor effect of the paclitaxel‑eluting membrane in a mouse model. Oncology Letters, 16, 4537-4542. https://doi.org/10.3892/ol.2018.9164
MLA
Park, J., Jeong, S., Lee, D. H., Maeng, J. H., Park, I. S., Park, S."Antitumor effect of the paclitaxel‑eluting membrane in a mouse model". Oncology Letters 16.4 (2018): 4537-4542.
Chicago
Park, J., Jeong, S., Lee, D. H., Maeng, J. H., Park, I. S., Park, S."Antitumor effect of the paclitaxel‑eluting membrane in a mouse model". Oncology Letters 16, no. 4 (2018): 4537-4542. https://doi.org/10.3892/ol.2018.9164